Frankel Laboratory, Center for Stem Cell Research, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Stem Cells. 2010 Jul;28(7):1270-80. doi: 10.1002/stem.448.
Tumor necrosis factor (TNF) family receptors/ligands are important participants in hematopoietic homeostasis, in particular as essential negative expansion regulators of differentiated clones. As a prominent injury cytokine, TNF-alpha has been traditionally considered to suppress donor hematopoietic stem and progenitor cell function after transplantation. We monitored the involvement of TNF receptors (TNF-R) 1 and 2 in murine hematopoietic cell engraftment and their inter-relationship with Fas. Transplantation of lineage-negative (lin(-)) bone marrow cells (BMC) from TNF receptor-deficient mice into wild-type recipients showed defective early engraftment and loss of durable hematopoietic contribution upon recovery of host hematopoiesis. Consistently, cells deficient in TNF receptors had reduced competitive capacity as compared to wild-type progenitors. The TNF receptors were acutely upregulated in bone marrow (BM)-homed donor cells (wild-type) early after transplantation, being expressed in 60%-75% of the donor cells after 6 days. Both TNF receptors were detected in fast cycling, early differentiating progenitors, and were ubiquitously expressed in the most primitive progenitors with long-term reconstituting potential (lin(-)c-kit(+) stem cell antigen (SCA)-1(+)). BM-homed donor cells were insensitive to apoptosis induced by TNF-alpha and Fas-ligand and their combination, despite reciprocal inductive cross talk between the TNF and Fas receptors. The engraftment supporting effect of TNF-alpha is attributed to stimulation of progenitors through TNF-R1, which involves activation of the caspase cascade. This stimulatory effect was not observed for TNF-R2, and this receptor did not assume redundant stimulatory function in TNFR1-deficient cells. It is concluded that TNF-alpha plays a tropic role early after transplantation, which is essential to successful progenitor engraftment.
肿瘤坏死因子 (TNF) 家族受体/配体是造血稳态的重要参与者,特别是作为分化克隆的必需负扩展调节剂。作为一种突出的损伤细胞因子,TNF-α 传统上被认为会抑制移植后供体造血干细胞和祖细胞的功能。我们监测了 TNF 受体 (TNF-R)1 和 2 在小鼠造血细胞植入中的参与及其与 Fas 的相互关系。从 TNF 受体缺陷小鼠中分离的谱系阴性 (lin(-)) 骨髓细胞 (BMC) 移植到野生型受体中显示早期植入缺陷,并在宿主造血恢复后丧失持久的造血贡献。一致地,与野生型祖细胞相比,缺乏 TNF 受体的细胞具有降低的竞争能力。移植后早期,骨髓 (BM) 归巢供体细胞 (野生型) 中 TNF 受体被急性上调,6 天后约有 60%-75%的供体细胞表达 TNF 受体。两种 TNF 受体均在快速循环、早期分化的祖细胞中检测到,并在具有长期重建潜力的最原始祖细胞 (lin(-)c-kit(+)干细胞抗原 (SCA)-1(+)) 中广泛表达。尽管 TNF 和 Fas 受体之间存在相互诱导的交叉对话,但 BM 归巢供体细胞对 TNF-α 和 Fas 配体及其组合诱导的凋亡不敏感。TNF-α 的植入支持作用归因于通过 TNF-R1 对祖细胞的刺激,这涉及半胱天冬酶级联的激活。这种刺激作用在 TNF-R2 中未观察到,并且该受体在 TNFR1 缺陷细胞中没有发挥冗余的刺激功能。结论是,TNF-α 在移植后早期发挥营养作用,这对于成功的祖细胞植入是必不可少的。